Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression-Reference-Cited by-同舟云学术

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

Published:2018-02-01 Issue:2 Volume:75 Page:139
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Daly Ella J.¹,Singh Jaskaran B.²,Fedgchin Maggie¹,Cooper Kimberly³,Lim Pilar⁴,Shelton Richard C.⁵,Thase Michael E.⁶,Winokur Andrew⁷⁸,Van Nueten Luc⁹,Manji Husseini¹,Drevets Wayne C.¹

Affiliation:

1. Department of Neuroscience, Janssen Research & Development LLC, Titusville, New Jersey

2. Department of Neuroscience, Janssen Research & Development LLC, San Diego, California

3. Department of Neuroscience, Janssen Research & Development LLC, Spring House, Pennsylvania

4. Department of Quantitative Sciences, Janssen Research & Development LLC, Titusville, New Jersey

5. Department of Psychiatry, University of Alabama School of Medicine, Birmingham

6. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia

7. Institute of Living, Hartford, Connecticut

8. Department of Psychiatry, UConn Health, Farmington, Connecticut

9. Department of Neuroscience, Janssen Research & Development, Beerse, Belgium

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Cited by 498 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychometric properties of the 23-Item Clinician Administered Dissociative States Scale (CADSS) in a psychological trauma population;Journal of Affective Disorders;2024-11

2. The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside;Brain Research;2024-11

3. Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseases;Ageing Research Reviews;2024-11

4. Combinatorial therapy with sub-effective Ro25-6981 and ZL006 ameliorates depressive-like behavior in single or combined stressed male mice;Biochemical and Biophysical Research Communications;2024-10

5. New treatments: Opportunities and challenges;Seminars in Perinatology;2024-10